Cyberonics, Inc. (NASDAQ:CYBX)

CAPS Rating: 2 out of 5

A neuromodulation company founded to design, develop and bring to market medical devices that provide a unique therapy, VNS Therapy, for the treatment of epilepsy, TRD and other debilitating neurological or psychiatric diseases and other disorders.

Recs

0
Player Avatar Osserp (< 20) Submitted: 1/24/2013 6:45:01 PM : Underperform Start Price: $43.76 CYBX Score: -4.85

Overvalued by around 240%, the science behind their product is inconclusive at best (according to various studies by governments, academia, and private enterprises), insiders have sold 823,000+ shares over the last year, and a whistleblower is filing a very large and ugly lawsuit against the company.I would short as soon as possible.

Featured Broker Partners


Advertisement